Afficher la notice abrégée

dc.contributor.editorHamdy Gad, Emad
dc.date.accessioned2021-04-20T16:03:11Z
dc.date.available2021-04-20T16:03:11Z
dc.date.issued2019
dc.identifierONIX_20210420_9781839628702_2459
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/67100
dc.description.abstractNon-alcoholic fatty liver disease (NAFLD) is a major medical challenge because of its increasing prevalence, difficulties in diagnosis, complex pathogenesis, and lack of approved therapies. In the near future, it will become the major form of chronic liver disease in adults and children and the leading indication for liver transplantation. It can be detected by noninvasive and invasive tools, and its treatment depends mainly on lifestyle modification to prevent disease progression and its related sequelae. This book provides information on NAFLD prevalence, etiology, pathogenesis, pathology, diagnosis, and treatment. Chapters cover such topics as experimental work related to the disease, other diseases related to NAFLD, and noninvasive tools for diagnosis.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJG Endocrinologyen_US
dc.subject.otherHepatology
dc.titleNonalcoholic Fatty Liver Disease
dc.title.alternativeAn Update
dc.typebook
oapen.identifier.doi10.5772/intechopen.78459
oapen.relation.isPublishedBy78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6
oapen.relation.isbn9781839628702
oapen.relation.isbn9781839628696
oapen.relation.isbn9781839628719
oapen.imprintIntechOpen
oapen.pages144


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/3.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/3.0/